0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hodgkin’s lymphoma (HL) -Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-328
Home | Market Reports |Health |Health Conditions
Hodgkins lymphoma Epidemiology Forecast to 2028

Hodgkin’s lymphoma (HL) -Epidemiology Forecast to 2028

Code: DELV-Epid-328
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Hodgkin’s lymphoma (HL) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hodgkin’s lymphoma (HL) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hodgkin’s lymphoma (HL) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hodgkin’s lymphoma (HL) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hodgkin’s lymphoma (HL) outlook. It also includes the explanation of changing trends of epidemiology outlining the Hodgkin’s lymphoma (HL) scenario.

Hodgkin’s lymphoma (HL) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hodgkin’s lymphoma (HL) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hodgkin’s lymphoma (HL) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hodgkin’s lymphoma (HL) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hodgkin’s lymphoma (HL)

Key assessments
• Patient Segmentation in Hodgkin’s lymphoma (HL)
• Hodgkin’s lymphoma (HL) Risk & Burden
• Factors driving growth in a specific Hodgkin’s lymphoma (HL) patient population

1. Report Introduction
2. Hodgkin’s lymphoma (HL) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hodgkin’s lymphoma (HL) in 2016
2.2. Patient Share Distribution of Hodgkin’s lymphoma (HL) in 2028
3. Disease Background and Overview: Hodgkin’s lymphoma (HL)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hodgkin’s lymphoma (HL) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hodgkin’s lymphoma (HL) in 7MM – By Countries
5. Epidemiology of Hodgkin’s lymphoma (HL) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.1.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) *
5.1.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.1.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.4.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.4.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.4.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.5.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.5.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.5.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.6.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.6.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.6.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.7.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.7.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.7.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.8.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.8.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.8.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.9.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.9.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.9.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
6. Unmet Needs of the Hodgkin’s lymphoma (HL)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM
Table 2: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Table 14: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)


List of Figures

Figure 1: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)

DelveInsight's "Hodgkin’s lymphoma (HL) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hodgkin’s lymphoma (HL) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hodgkin’s lymphoma (HL) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hodgkin’s lymphoma (HL) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hodgkin’s lymphoma (HL) outlook. It also includes the explanation of changing trends of epidemiology outlining the Hodgkin’s lymphoma (HL) scenario.

Hodgkin’s lymphoma (HL) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hodgkin’s lymphoma (HL) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hodgkin’s lymphoma (HL) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hodgkin’s lymphoma (HL) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hodgkin’s lymphoma (HL)

Key assessments
• Patient Segmentation in Hodgkin’s lymphoma (HL)
• Hodgkin’s lymphoma (HL) Risk & Burden
• Factors driving growth in a specific Hodgkin’s lymphoma (HL) patient population

Read More

1. Report Introduction
2. Hodgkin’s lymphoma (HL) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hodgkin’s lymphoma (HL) in 2016
2.2. Patient Share Distribution of Hodgkin’s lymphoma (HL) in 2028
3. Disease Background and Overview: Hodgkin’s lymphoma (HL)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hodgkin’s lymphoma (HL) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hodgkin’s lymphoma (HL) in 7MM – By Countries
5. Epidemiology of Hodgkin’s lymphoma (HL) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.1.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) *
5.1.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.1.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.4.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.4.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.4.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.5.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.5.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.5.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.6.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.6.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.6.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.7.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.7.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.7.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.8.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.8.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.8.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL)
5.9.3. Sub-Type Specific cases of the Hodgkin’s lymphoma (HL)*
5.9.4. Sex- Specific Cases of the Hodgkin’s lymphoma (HL)*
5.9.5. Diagnosed Cases of the Hodgkin’s lymphoma (HL)
6. Unmet Needs of the Hodgkin’s lymphoma (HL)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

List of Tables

Table 1: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM
Table 2: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Table 14: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)


List of Figures

Figure 1: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hodgkin’s lymphoma (HL) in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Early Cancer Screening Tests Market Size Status and Forecast 2021 2027
Global Early Cancer Screening Tests Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30U5085
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Quick relief Asthma Drugs Market Size Status and Forecast 2021 2027
Global Quick-relief Asthma Drugs Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20G5207
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Bare Metal Coronary Artery Stent Sales Market Report 2021
Global Bare Metal Coronary Artery Stent Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-36Z5191
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Pets Pain Relief and Prevention Market Research Report 2021
Global Pets Pain Relief and Prevention Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-28J2423
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0